Insider Transactions in Q4 2022 at Biovie Inc. (BIVI)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 23
2022
|
Steve Gorlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,240
+28.9%
|
-
|
|
Nov 23
2022
|
James Paul Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
43,578
+38.84%
|
-
|
|
Nov 23
2022
|
Penelope Markham EVP Liver Cirrhosis R&D |
BUY
Grant, award, or other acquisition
|
Direct |
39,624
+44.06%
|
-
|
|
Nov 23
2022
|
Cuong V Do President & CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
79,248
+25.23%
|
-
|
|
Nov 23
2022
|
Joanne Wendy Kim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,624
+48.77%
|
-
|
|
Nov 23
2022
|
Richard J Berman Director |
BUY
Grant, award, or other acquisition
|
Direct |
43,578
+49.1%
|
-
|
|
Nov 23
2022
|
Clarence N. Ahlem EVP Neuroscience Product Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
39,624
+50.0%
|
-
|
|
Nov 23
2022
|
Joseph M Palumbo Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,624
+50.0%
|
-
|
|
Nov 23
2022
|
Robert J Hariri Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,240
+50.0%
|
-
|
|
Nov 23
2022
|
Christopher Reading EVP Neuroscience R&D |
BUY
Grant, award, or other acquisition
|
Direct |
39,624
+50.0%
|
-
|